Reduction in Ischemic Events with Ticagrelor in Diabetic Patients from the PEGASUS-TIMI 54 Trial Deepak L. Bhatt, MD, MPH, Marc P. Bonaca, MD, MPH, Sameer. - ppt download
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54 | Journal of the American Heart Association
PDF) Implications of the PEGASUS-TIMI 54 trial for US clinical practice
PEGASUS TIMI 54 – SIAC
PEGASUS TIMI 54
PEGASUS-TIMI 54 – TIMI STUDY GROUP
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54 - ScienceDirect
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS- TIMI. - ppt download
PEGASUS TIMI 54
Implications of the PEGASUS-TIMI 54 trial for US clinical practice | Open Heart
Three-year safety and efficacy outcomes of the PEGASUS-TIMI-54 trial. a... | Download Scientific Diagram
PEGASUS TIMI 54 PREVENCION DE EVENTOS CARDIOVASCULARES EN PACIENTES CON IAM PREVIO - YouTube
Abstract 16658: Patient Selection for Long-Term Secondary Prevention With Ticagrelor: Insights From PEGASUS-TIMI 54 | Circulation
TCT 78: Efficacy of Long-term Ticagrelor in Stented Patients in PEGASUS-TIMI 54 | tctmd.com
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin–Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial -
PEGASUS-TIMI 54: la duplice antiaggregazione con aspirina e ticagrelor a lungo termine riduce gli eventi trombotici ma aumenta le emorragie in pazienti con pregresso infarto miocardico - CardioInfo
Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations | The BMJ
Presentazione standard di PowerPoint
Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54 | tctmd.com
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction | NEJM
Long-Term Tolerability of Ticagrelor for Secondary Prevention: Insights from PEGASUS-TIMI 54 Trial Marc P. Bonaca, MD, MPH on behalf of the PEGASUS- TIMI. - ppt download
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54 | Journal of the American Heart Association
